(VIANEWS) – ELEC.STRASBOURG (ELEC.PA), CREDIT AGRICOLE (ACA.PA), NEURONES (NRO.PA) are the highest payout ratio stocks on this list.
We have congregated information concerning stocks with the highest payout ratio up to now. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. ELEC.STRASBOURG (ELEC.PA)
106.54% Payout Ratio
Électricite de Strasbourg Société Anonyme engages in the supply of electricity and natural gas to individuals, businesses, and local authorities in France. It is also involved in the design, construction, and operation of electrical engineering, industrial, and public lighting facilities, as well as heating networks; provision of collective catering engineering and energy renovation services; and technical management and optimization of energy installations. The company was founded in 1899 and is based in Strasbourg, France. Électricite de Strasbourg Société Anonyme is a subsidiary of EDF Développement Environnement SA.
Earnings Per Share
As for profitability, ELEC.STRASBOURG has a trailing twelve months EPS of €7.97.
PE Ratio
ELEC.STRASBOURG has a trailing twelve months price to earnings ratio of 11.99. Meaning, the purchaser of the share is investing €11.99 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.05%.
Yearly Top and Bottom Value
ELEC.STRASBOURG’s stock is valued at €95.60 at 11:10 EST, way below its 52-week high of €110.00 and above its 52-week low of €90.60.
2. CREDIT AGRICOLE (ACA.PA)
63.64% Payout Ratio
Crédit Agricole S.A. provides retail, corporate, insurance, and investment banking products and services worldwide. It operates through Asset Gathering; Large Customers; Specialised Financial Services; French Retail Banking – LCL; and International Retail Banking. The company offers banking products and services, including savings and current accounts and deposits, finance, payments, and flow management services; consumer finance products; and banking and specialized financial services. It also provides wealth management services that allow individual customers to manage, protect, and transfer their assets, as well as other asset management services; and savings/retirement, death and disability/creditor/group, and property and casualty insurance products. In addition, the company offers financing solutions for property and equipment investment and renewal requirements; trade receivable financing and management solutions for corporates; and financing services for renewable energy and public infrastructure projects, as well as leasing services. Further, it provides investment banking, structured finance, international trade finance, commercial banking, capital market, and syndication services; and asset servicing solutions for investment products, as well as various asset classes, such as execution, clearing, forex, security lending and borrowing, custody, depositary bank, fund administration, middle-office outsourcing solutions, and fund distribution support and issuer services. The company serves retail customers, corporates, banks and financial institutions, government agencies, and local authorities. Crédit Agricole S.A. was founded in 1894 and is headquartered in Montrouge, France. Crédit Agricole S.A. operates as a subsidiary of SAS Rue La Boétie.
Earnings Per Share
As for profitability, CREDIT AGRICOLE has a trailing twelve months EPS of €1.59.
PE Ratio
CREDIT AGRICOLE has a trailing twelve months price to earnings ratio of 6.62. Meaning, the purchaser of the share is investing €6.62 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.25%.
3. NEURONES (NRO.PA)
58.48% Payout Ratio
Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. Its infrastructure services include infrastructure management, clouds, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. The company also provides application services in the areas of SAP integration and outsourcing; mobility, data, IoT, digital, agile, UX/UI, and DevOps; IT consulting for finance, big data, AI and blockchain; content management, business process management, paperless process; and IT training and working with change management. In addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, DevOps, CI/CD, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, UX/UI, and digital marketing, as well as internal process digitization, ECM/BPM, RPA, dematerialization, AI, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. The company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. Neurones S.A. was founded in 1984 and is headquartered in Nanterre, France.
Earnings Per Share
As for profitability, NEURONES has a trailing twelve months EPS of €1.27.
PE Ratio
NEURONES has a trailing twelve months price to earnings ratio of 32.24. Meaning, the purchaser of the share is investing €32.24 for every euro of annual earnings.
Moving Average
NEURONES’s worth is higher than its 50-day moving average of €40.20 and way above its 200-day moving average of €36.89.
Volume
Today’s last reported volume for NEURONES is 617 which is 78.54% below its average volume of 2876.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 8, 2022, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 2.4%.
4. ALMUNDA PRO NV (AMUND.AS)
45.45% Payout Ratio
Almunda Professionals N.V., a business and IT consultancy company, provides business services in the financial sector. It offers consultancy services in the areas of regulatory change, digital transformation, information security, and information services. The company was formerly known as Novisource N.V. and changed its name to Almunda Professionals N.V. in August 2021. Almunda Professionals N.V. was founded in 2001 and is based in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ALMUNDA PRO NV has a trailing twelve months EPS of €0.11.
PE Ratio
ALMUNDA PRO NV has a trailing twelve months price to earnings ratio of 11.36. Meaning, the purchaser of the share is investing €11.36 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.86%.
Volume
Today’s last reported volume for ALMUNDA PRO NV is 785 which is 57.29% below its average volume of 1838.
Moving Average
ALMUNDA PRO NV’s worth is under its 50-day moving average of €1.27 and under its 200-day moving average of €1.28.
5. CHRISTIAN DIOR (CDI.PA)
33.07% Payout Ratio
Christian Dior SE, through its subsidiaries, engages in the production, distribution, and retail of fashion and leather goods, wines and spirits, perfumes and cosmetics, and watches and jewelry worldwide. The company offers its fashion and leather goods under the Louis Vuitton, Christian Dior Couture, Loewe, Marc Jacobs, Celine, Kenzo, Givenchy, Pink Shirtmaker, Emilio Pucci, Berluti, Loro Piana, Rimowa brand names; wines and spirits under the Hennessy, Glenmorangie, Ardbeg, a Belvedere, Volcán de mi Tierra, Moët & Chandon, Dom Pérignon, Veuve Clicquot, Krug, Château d'Yquem, Ruinart, Belvedere, Glenmorangie, Newton Vineyards, Bodega Numanthia, and Château d'Esclans brand names; and perfumes and cosmetics under the Parfums Christian Dior, Guerlain, Parfums Givenchy, Make Up For Ever, Benefit Cosmetics, Fresh, Acqua di Parma, KVD Vegan Beauty, Fenty, Ole Henriksen, and Maison Francis Kurkdjian brand names. It also provides watches and jewelry under the Tiffany, Bvlgari, TAG Heuer, Zenith, Hublot, Chaumet, and Fred brand names. In addition, the company operates retail stores under the DFS Galleria, Sephora, Le Bon Marché, and Ile de Beauté names; publishes Le Parisien- Aujourd'hui en France, a daily newspaper; designs and builds yachts; and operates the Cova pastry shops. Further, it is involved in real estate activities under the La Samaritaine brand name; and hotel business. The company sells its products through store network, including e-commerce websites; and agents and distributors. As of December 31, 2021, it operated 5,556 stores. The company was incorporated in 1946 and is headquartered in Paris, France. Christian Dior SE was formerly a subsidiary of Semyrhamis SA.
Earnings Per Share
As for profitability, CHRISTIAN DIOR has a trailing twelve months EPS of €10.7.
PE Ratio
CHRISTIAN DIOR has a trailing twelve months price to earnings ratio of 72.32. Meaning, the purchaser of the share is investing €72.32 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.21%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.4%, now sitting on 79.18B for the twelve trailing months.
6. BOIRON (BOI.PA)
32.87% Payout Ratio
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €1.5.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 27.45. Meaning, the purchaser of the share is investing €27.45 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.
Sales Growth
BOIRON’s sales growth is 17.3% for the current quarter and 17.3% for the next.
